title: The treatment of chronic myeloid leukemia, data from Gujarat Cancer and Research Institute, Ahmedabad.
abstract: Gujarat Cancer and Research Institute, Ahmedabad presented data of total 840 patients, out of which 775 (90%) were in chronic phase. Complete hematological response (CHR) was seen in 96% of patients and median time to achieve (CHR) was 2 months. Complete cytogenetic response was seen in 36%.
authors: Department of Medical Oncology, Gujarat Cancer and Research Institute, Ahmedabad, Gujarat, India.
authors: Sandip A
authors: SA
authors: Shah
keywords: Chronic myeloid leukemia; Gujarat cancer and research institute; imatinib